These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 17074304)
1. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis. Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304 [TBL] [Abstract][Full Text] [Related]
2. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells. Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449 [TBL] [Abstract][Full Text] [Related]
3. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts. Hao GH; Niu XL; Gao DF; Wei J; Wang NP Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065 [TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Rupérez M; Lorenzo O; Blanco-Colio LM; Esteban V; Egido J; Ruiz-Ortega M Circulation; 2003 Sep; 108(12):1499-505. PubMed ID: 12952842 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213 [TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071 [TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative effect of rosiglitazone on angiotensin II-induced vascular smooth muscle cell proliferation is mediated by the mTOR pathway. Kim JS; Kim IK; Lee SY; Song BW; Cha MJ; Song H; Choi E; Lim S; Ham O; Jang Y; Hwang KC Cell Biol Int; 2012 Mar; 36(3):305-10. PubMed ID: 22050182 [TBL] [Abstract][Full Text] [Related]
8. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Ji Y; Liu J; Wang Z; Liu N; Gou W Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898 [TBL] [Abstract][Full Text] [Related]
9. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro. Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478 [TBL] [Abstract][Full Text] [Related]
10. Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells. Rodriguez-Vita J; Ruiz-Ortega M; Rupérez M; Esteban V; Sanchez-López E; Plaza JJ; Egido J Circ Res; 2005 Jul; 97(2):125-34. PubMed ID: 15976312 [TBL] [Abstract][Full Text] [Related]
11. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. Benkirane K; Amiri F; Diep QN; El Mabrouk M; Schiffrin EL Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H390-7. PubMed ID: 16155101 [TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. Fu M; Zhang J; Zhu X; Myles DE; Willson TM; Liu X; Chen YE J Biol Chem; 2001 Dec; 276(49):45888-94. PubMed ID: 11590167 [TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo. Benkirane K; Viel EC; Amiri F; Schiffrin EL Hypertension; 2006 Jan; 47(1):102-8. PubMed ID: 16344371 [TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation. Meng Z; Yu XH; Chen J; Li L; Li S Acta Pharmacol Sin; 2014 Oct; 35(10):1247-56. PubMed ID: 25132338 [TBL] [Abstract][Full Text] [Related]
15. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. Nuwormegbe SA; Sohn JH; Kim SW Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722 [TBL] [Abstract][Full Text] [Related]
16. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1. Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Finckenberg P; Inkinen K; Ahonen J; Merasto S; Louhelainen M; Vapaatalo H; Müller D; Ganten D; Luft F; Mervaala E Am J Pathol; 2003 Jul; 163(1):355-66. PubMed ID: 12819040 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Sánchez-López E; Rodriguez-Vita J; Cartier C; Rupérez M; Esteban V; Carvajal G; Rodrígues-Díez R; Plaza JJ; Egido J; Ruiz-Ortega M Am J Physiol Renal Physiol; 2008 Jan; 294(1):F149-60. PubMed ID: 17989112 [TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Zheng S; Chen A Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G883-93. PubMed ID: 16306131 [TBL] [Abstract][Full Text] [Related]
20. Activation of PPAR-γ inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor. Yu WW; Xia Q; Wu Y; Bu QY J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):652-656. PubMed ID: 25318873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]